Zheng Zheng

Zheng Zheng has extensive experience in analytical development, with a focus on HPLC, CE, and LC-MS methods. They have worked at various companies and institutions, starting with Arcturus Therapeutics in 2022 as a Scientist II in Analytical Development. In this role, Zheng Zheng is responsible for project management, review/audit of CRO activities, and investigation of trends and deviations during routine and external testing.

Before joining Arcturus Therapeutics, Zheng Zheng worked at Cellics Therapeutics, Inc. as a Senior Analytical Scientist from July 2021 to December 2021.

Prior to that, Zheng Zheng had a long tenure at Vertex Pharmaceuticals, starting as a Scientist I in Analytical Development in July 2016 and later promoted to Scientist II. Their responsibilities at Vertex Pharmaceuticals included method development, qualification, validation, and batch analysis.

Zheng Zheng's work experience also includes roles at the University of Michigan, where they served as a Graduate Student Researcher and Graduate Student Instructor from 2011 to 2016. Additionally, they gained research experience as an Undergraduate Researcher at Middlebury College from 2010 to 2011.

Zheng Zheng received a Bachelor's Degree in Environmental Chemistry from Middlebury College in 2011. Subsequently, from 2011 to 2016, they pursued a Doctor of Philosophy (Ph.D.) in Analytical Chemistry at the University of Michigan.